-+ 0.00%
-+ 0.00%
-+ 0.00%

ZAI LAB ANNOUNCES ACCEPTANCE OF SUPPLEMENTAL NEW DRUG APPLICATION FOR REPOTRECTINIB FOR PATIENTS WITH NTRK-POSITIVE SOLID TUMORS

Reuters·04/21/2025 11:30:00

Please log in to view news